Skip to content
VuFind
Advanced
  • A human serum albumin–thioredo...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
A human serum albumin–thioredoxin fusion protein prevents experimental contrast-induced nephropathy
QR Code

A human serum albumin–thioredoxin fusion protein prevents experimental contrast-induced nephropathy

Bibliographic Details
Main Authors: Kodama, A., Watanabe, H., Tanaka, R., Tanaka, H., Chuang, Victor, Miyamoto, Y., Wu, Q., Endo, M., Hamasaki, K., Ishima, Y., Fukagawa, M., Otagiri, M., Maruyama, T.
Format: Journal Article
Published: Nature Publishing Group 2013
Online Access:http://www.nature.com/ki/index.html
http://hdl.handle.net/20.500.11937/49488
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.nature.com/ki/index.html
http://hdl.handle.net/20.500.11937/49488

Similar Items

  • Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression
    by: Tanaka, R., et al.
    Published: (2013)
  • Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity
    by: Kodama, A., et al.
    Published: (2014)
  • Albumin fusion prolongs the antioxidant and anti-inflammatory activities of thioredoxin in mice with acetaminophen-induced hepatitis
    by: Tanaka, R., et al.
    Published: (2014)
  • Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury
    by: Furukawa, M., et al.
    Published: (2011)
  • Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice
    by: Tanaka, R., et al.
    Published: (2014)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips